Life-saving new drug DOUBLES survival for world’s deadliest cancer – and slashes risk of death by a third

A NEW drug could double the survival rates of one of the deadliest forms of cancer, scientists say. Called elraglusib, it breaks down the protective web around tumours so that chemotherapy can better penetrate them. It may also reduce patients' risk of death by a third. Pancreatic cancer affects 10,500 people every year in the...